颅内压 (ICP) 监测设备市场规模 - 按产品、技术、应用、最终用途和预测，2024 年至 2032 年

在医疗保健基础设施的进步和对非侵入性监测方法的需求不断增长的推动下，2024年至2032年全球颅内压（ICP）监测设备市场规模的复合年增长率将达到6.8%。医疗保健设施的改善，尤其是在发展中地区，正在提高神经外科手术的可近性，包括颅内压监测。此外，患者和医疗保健提供者对非侵入性或微创监测解决方案的偏好日益增长。这些趋势标誌着向更有效、对患者友好的监测方案的转变，推动了 ICP 设备的创新并扩大了其市场规模。

颅内压 (ICP) 监测设备产业根据产品、技术、应用、最终用途和地区进行细分。

由于门诊护理趋势不断增强，诊所提供便利的监测服务，到 2032 年，诊所业务将显着改善。技术的进步促进了紧凑且用户友好的监测解决方案的开发，这些解决方案与诊所环境完美契合。随着专业神经科诊所数量的不断增加以及对高效脑健康服务的关注，诊所在管理神经系统疾病方面正变得至关重要，对更广阔的市场前景做出了重大贡献。

到 2032 年，脑出血领域的颅内压 (ICP) 监测设备市场份额将大幅成长，原因是脑出血患者对持续监测的迫切需求，因为这有助于早期发现和介入。由于脑出血会带来颅内压升高的重大风险，因此对监测设备的需求很高，以防止继发性脑损伤。非侵入式监测选项等技术进步进一步推动了 ICP 监测设备市场中这一细分市场的成长。

由于医疗基础设施的蓬勃发展、老年人口的增加以及先进医疗技术的普及，亚太地区颅内压 (ICP) 监测设备产业份额从 2024 年到 2032 年将呈现显着的复合年增长率。该地区脑外伤和神经系统疾病发病率的增加也导致了这一趋势。透过积极主动地实现医疗保健现代化以及对研发的大量投资，亚太地区将成为颅内压 (ICP) 监测设备市场成长的关键贡献者。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

• 产业生态系统分析
• 产业影响力
  • 成长动力
    • 各种神经系统疾病和创伤事故的盛行率不断增加
    • 新技术的进步
    • 不断增长的政府措施和政策
    • 提高认识和筛检计划
  • 产业陷阱与挑战
    • 这些监控设备的成本很高
    • 相关併发症和不良反应
• 成长潜力分析
• 监管环境
• 技术景观
• 波特的分析
• PESTEL分析

第 4 章：竞争格局

• 介绍
• 公司市占率分析
• 竞争定位矩阵
• 战略展望矩阵

第 5 章：市场估计与预测：按产品划分，2018 年 - 2032 年

• 主要趋势
• 产品与系统
• 解决方案和平台

第 6 章：市场估计与预测：按技术划分，2018 年 - 2032 年

• 主要趋势
• 侵入性
  • 脑室外引流（EVD）
  • 微感测器ICP监测
• 非侵入性
  • 经颅多普勒超音波检查
  • 鼓膜移位（TMD）
  • 视神经鞘直径
  • 核磁共振/CT
  • 脑电图
  • 眼底镜检查（视乳头水肿）

第 7 章：市场估计与预测：按应用划分，2018 年 - 2032 年

• 主要趋势
• 创伤性脑损伤
• 脑出血
• 脑膜炎
• 蜘蛛网膜下腔出血
• 脑脊髓液管理
• 偏头痛
• 中风
• 脑积水
• 其他应用

第 8 章：市场估计与预测：按最终用途，2018 - 2032 年

• 主要趋势
• 医院
• 诊所
• 诊断实验室
• 其他最终用户

第 9 章：市场估计与预测：按地区划分，2018 年 - 2032 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
  • 亚太地区其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地区
• 中东和非洲
  • 沙乌地阿拉伯
  • 南非
  • 阿联酋
  • 中东和非洲其他地区

第 10 章：公司简介

• Brain4Care Inc.
• CranioSense, LLC.
• HeadSense Medical Ltd
• Integra LifeScience Holdings Corporation
• Johnson & Johnson
• Luciole Medical AG
• Medtronic plc
• Natus Medical Incorporated
• RAUMEDIC AG
• Sophysa
• Vittamed Corporation

Global Intracranial Pressure (ICP) Monitoring Devices Market size will record a 6.8% CAGR from 2024 to 2032, propelled by advancements in healthcare infrastructure and the increasing demand for non-invasive monitoring methods. Improved healthcare facilities, especially in developing regions, are enhancing access to neurosurgical procedures, including ICP monitoring. Furthermore, the preference for non-invasive or minimally invasive monitoring solutions is growing among patients and healthcare providers. These trends signify a shift towards more effective, patient-friendly monitoring options, driving innovation in ICP devices and expanding their market size.

The intracranial pressure (ICP) monitoring devices industry is segmented based on offering, technology, application, end-use, and region.

The clinics segment will encounter a marked upturn by 2032 due to the increasing trend toward outpatient care, where clinics offer convenient access to monitoring services. Advancements in technology have led to the development of compact and user-friendly monitoring solutions that align well with the clinic environment. With a rising number of specialized neurology clinics and a focus on efficient brain health services, clinics are becoming pivotal in managing neurological conditions, contributing significantly to the broader market outlook.

The intracranial pressure (ICP) monitoring devices market share from intracerebral hemorrhage segment will witness a considerable upsurge by 2032, fueled by the critical need for continuous monitoring in patients with this condition, as it helps in early detection and intervention. As intracerebral hemorrhage poses significant risks of increased intracranial pressure, the demand for monitoring devices is high to prevent secondary brain injury. Advancements in technology, such as non-invasive monitoring options, further drive the growth of this segment within the ICP monitoring devices market.

Asia Pacific intracranial pressure (ICP) monitoring devices industry share will exhibit a remarkable CAGR from 2024 to 2032, attributed to burgeoning healthcare infrastructure, a rising geriatric population, and expanding access to advanced medical technologies. The region's increasing incidence of traumatic brain injuries and neurological disorders also contributes to this trend. With a proactive approach to healthcare modernization and substantial investments in research and development, Asia Pacific will stand as a key contributor to the growth of the intracranial pressure (ICP) monitoring devices market.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definition
• 1.2 Base estimates & calculations
• 1.3 Data collection
• 1.4 Forecast calculations
• 1.5 Data sources
  • 1.5.1 Primary
  • 1.5.2 Secondary
    • 1.5.2.1 Paid sources
    • 1.5.2.2 Public sources

Chapter 2 Executive Summary

• 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of various neurological disorders and traumatic accidents
    • 3.2.1.2 Advancements in new technologies
    • 3.2.1.3 Growing government initiatives and policies
    • 3.2.1.4 Rising awareness and screening programs
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High cost associated with these monitoring devices
    • 3.2.2.2 Related complications and adverse effects
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technological landscape
• 3.6 Porter's analysis
  • 3.6.1 Supplier power
  • 3.6.2 Buyer power
  • 3.6.3 Threat of new entrants
  • 3.6.4 Threat of substitutes
  • 3.6.5 Industry rivalry
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Competitive positioning matrix
• 4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Offering, 2018 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Products & systems
• 5.3 Solutions & platforms

Chapter 6 Market Estimates and Forecast, By Technology, 2018 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Invasive
  • 6.2.1 External ventricular drainage (EVD)
  • 6.2.2 Microtransducer ICP monitoring
• 6.3 Non-invasive
  • 6.3.1 Transcranial doppler ultrasonography
  • 6.3.2 Tympanic membrane displacement (TMD)
  • 6.3.3 Optic nerve sheath diameter
  • 6.3.4 MRI/CT
  • 6.3.5 Electroencephalography
  • 6.3.6 Fundoscopy (Papilledema)

Chapter 7 Market Estimates and Forecast, By Application, 2018 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Traumatic brain injury
• 7.3 Intracerebral hemorrhage
• 7.4 Meningitis
• 7.5 Subarachnoid hemorrhage
• 7.6 CSF management
• 7.7 Migraine
• 7.8 Stroke
• 7.9 Hydrocephalus
• 7.10 Other applications

Chapter 8 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Hospitals
• 8.3 Clinics
• 8.4 Diagnostic laboratories
• 8.5 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Italy
  • 9.3.5 Spain
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
  • 9.4.6 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
  • 9.5.4 Rest of Latin America
• 9.6 Middle East and Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 South Africa
  • 9.6.3 UAE
  • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

• 10.1 Brain4Care Inc.
• 10.2 CranioSense, LLC.
• 10.3 HeadSense Medical Ltd
• 10.4 Integra LifeScience Holdings Corporation
• 10.5 Johnson & Johnson
• 10.6 Luciole Medical AG
• 10.7 Medtronic plc
• 10.8 Natus Medical Incorporated
• 10.9 RAUMEDIC AG
• 10.10 Sophysa
• 10.11 Vittamed Corporation